![](/imager/uploads/logos/58681/Avicenna_logo_black_117378e58441a39758ec294c229f7090.webp)
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery
Genetically modifying cells — for example, to produce biologic drugs — is a costly, protracted, trial-and-error process because biology still lacks the design and modeling tools common in other engineering disciplines. Asimov offers a cloud-based computer-aided design platform for biology called Kernel that enables users to design and debug genetic systems; models like the Genetic Simulator that predict how those systems will behave; and standardized biological “parts,” such as customized Chinese hamster ovary that can produce specified antibodies and proteins. By integrating CAD, data-driven models, and synthetic biology tools, Asimov aims to provide drug designers with powerful abstractions for specifying a cell’s performance.
Using AI to speed through the last mile of drug discovery
Finding precisely tuned viral vectors for gene therapy in CNS disorders
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing